GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
11 sept. 2023 08h30 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
01 sept. 2023 10h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health,...
Annual Results – Momentum Building on our Commercial Plans
30 août 2023 08h45 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health,...
Genetic Technologies Limited Announces Updated Investor Presentation
09 août 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG, “Company”), a global leader in genomics-based tests in health, wellness and serious...
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
28 juil. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness...
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
21 juil. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness and serious disease,...
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
23 mai 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious...
New Publication Validates geneType for Melanoma Risk Assessment
28 avr. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and...
Quarterly Business Update – March 2023
27 avr. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health,...
Publication Validates geneType Prostate Cancer Risk Test
19 avr. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and...